返回 Agenda
Session 10 Track 4: Electronic Product Information (ePI): A Digital Passport for Therapeutic Product Information
Session Chair(s)
Jo English
VP and General Manager, Enterprise Technology
Calyx, United Kingdom
This session will provide a holistic view of electronic Product Information (ePI), emphasizing its significance in delivering timely drug information to patients and healthcare providers. You’ll gain insights into the current status of ePI adoption and discover the essential factors needed for its global implementation.
Learning Objective : At the conclusion of this session, participants should be able to:- Understand the purpose of ePI & how it fits within regulatory ecosystem
- Highlight the current state of ePI adoption globally
- Describe the benefits of adopting ePI, best practices for implementation, and barriers to adoption
- Explain how ePI interacts with global data standard initiatives & Why it matters
Speaker(s)
Electronic Product Information (ePI): A Digital Passport for Therapeutic Product Information; case study : "Unlocking ePI: A Possible Solution to Drug Shortage Management"
Katja Pecjak, MPharm
Billev Pharma East Ltd., Slovenia
Director BD, Sales and Marketing
Electronic Product Information (ePI): A Digital Passport for Therapeutic Product Information
G. Scott Gordon, PhD
FDA, United States
Senior Health Informatics Officer, OSP, CDER
Speaker
Cesar Vinces
Accumulus Synergy, United States
EU Interim and International Policy Lead
Speaker
Hilmar Hamann, PhD
European Medicines Agency, Netherlands
Head of Information Management
Speaker
Niklas Jaenich, PhD, RPh
Boehringer Ingelheim, Germany
Head of Global Labeling Operations and Digitization